Speak directly to the analyst to clarify any post sales queries you may have.
The arthroscopy market is rapidly advancing, driven by consistent innovation in minimally invasive orthopedic procedures and evolving healthcare delivery models. Senior executives evaluating this sector will find a landscape shaped by technology adoption, changing regulatory environments, and dynamic patient demand.
Market Snapshot: Arthroscopy Market Growth and Dynamics
The Arthroscopy Market grew from USD 18.06 billion in 2024 to USD 19.69 billion in 2025. It is expected to continue growing at a CAGR of 9.13%, reaching USD 36.37 billion by 2032. This robust expansion is fueled by the increasing preference for minimally invasive surgeries, heightened adoption of advanced visualization platforms, and integration of ergonomic instruments designed for precision and safety.
Scope & Segmentation: Addressing the Arthroscopy Market Ecosystem
- Product Type: Implants, Instruments, Accessories, Arthroscopes, Pumps, Radiofrequency Probes, Shavers, Fluid Management Systems, Rf Systems, Visualization Systems
- Patient Type: Adults, Pediatrics
- Application: Ankle, Elbow, Hip, Knee, Shoulder, Wrist
- End User: Ambulatory Surgery Centers, Hospitals & Clinics
- Region: Americas, North America (United States, Canada, Mexico), Latin America (Brazil, Argentina, Chile, Colombia, Peru), Europe (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland), Middle East (United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel), Africa (South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan)
- Leading Companies: Stryker Corporation, Johnson & Johnson, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Arthrex, Inc., CONMED Corporation, Karl Storz SE & Co. KG, B. Braun Melsungen AG, Medtronic plc, Olympus Corporation
Technological innovations underpin segmentation relevance, with fluid management systems, sensor-enabled shavers, and visualization consoles enabling procedure customization for varying joint anatomies.
Key Takeaways for Arthroscopy Market Stakeholders
- Minimally invasive arthroscopic methods are now foundational to orthopedic treatment approaches, leading to reduced recovery times and expanded procedural indications.
- Technological partnerships among device manufacturers, software developers, and hospitals are accelerating adoption of data-driven surgical tools with built-in analytics capabilities.
- The regulatory landscape and reimbursement incentives in established and emerging economies are shaping technology diffusion and access, particularly in ambulatory surgery centers.
- Customized implants, ergonomic pediatric instruments, and digital health integration are broadening the spectrum of patient eligibility and clinical use cases across age demographics.
- Collaborative business models and joint ventures are driving rapid product introductions and expansion into new clinical settings and global markets.
Tariff Impact: Navigating Supply Chain Disruption
Recent United States tariffs have introduced higher import duties across orthopedic device categories, increasing cost pressures along supply chains. Manufacturers are re-evaluating sourcing, adopting nearshoring, and forging strategic alliances with domestic suppliers to mitigate such fluctuation risks. Hospitals and ambulatory surgery centers are responding by securing long-term procurement contracts and optimizing inventory, emphasizing stable access to essential instruments. Collaborative mitigation strategies—such as localization of assembly and regulatory streamlining—are further strengthening supply chain resilience and maintaining quality standards even under challenging trade conditions.
Methodology & Data Sources
This comprehensive analysis integrates primary interviews with orthopedic surgeons, procurement executives, engineers, and regulators, complemented by secondary research from industry publications, regulatory filings, and clinical guidelines. Data triangulation and peer review by subject-matter experts underpin the credibility of findings and insights.
The Importance of This Arthroscopy Market Report
- Enables senior decision-makers to align investment strategies with innovation trends and emerging clinical priorities.
- Provides actionable segmentation and regional intelligence to inform market entry, portfolio development, and procurement planning.
- Equips stakeholders to anticipate regulatory, reimbursement, and supply chain shifts impacting technology adoption across diverse settings.
Conclusion
Advancements in arthroscopy are reshaping orthopedic care, driven by continuous innovation and strategic adaptations across technologies, regions, and business models. Informed decisions in this dynamic market will yield substantial benefits for technology developers, providers, and patients alike.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
List of Figures
Samples

LOADING...
Companies Mentioned
The key companies profiled in this Arthroscopy market report include:- Stryker Corporation
- Johnson & Johnson
- Zimmer Biomet Holdings, Inc.
- Smith & Nephew plc
- Arthrex, Inc.
- CONMED Corporation
- Karl Storz SE & Co. KG
- B. Braun Melsungen AG
- Medtronic plc
- Olympus Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 180 |
| Published | October 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 19.69 Billion |
| Forecasted Market Value ( USD | $ 36.37 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |


